Bill Status of HB 1102   104th General Assembly

Short Description:  INS CD-CANCER SCREENINGS

House Sponsors
Rep. Jed Davis

Last Action  View All Actions

DateChamber Action
  3/21/2025HouseRule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance
215 ILCS 5/356u

Synopsis As Introduced
Amends the Illinois Insurance Code. In a provision concerning coverage of certain cancer screenings, adds having a high level of CA-125, as indicated by a blood test screening, to the definition of "at risk for ovarian cancer". Provides that "surveillance tests for ovarian cancer" means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings (instead of an annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination). Effective January 1, 2027.

Actions 
DateChamber Action
  1/3/2025HousePrefiled with Clerk by Rep. Jed Davis
  1/9/2025HouseFirst Reading
  1/9/2025HouseReferred to Rules Committee
  2/4/2025HouseAssigned to Insurance Committee
  3/12/2025HouseTo Insurance Main Subcommittee
  3/18/2025HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Jed Davis
  3/18/2025HouseHouse Committee Amendment No. 1 Referred to Rules Committee
  3/19/2025HouseHouse Committee Amendment No. 1 Rules Refers to Insurance Committee
  3/21/2025HouseRule 19(a) / Re-referred to Rules Committee
  3/21/2025HouseHouse Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

Back To Top